What sleep medication can be safely added to a regimen of Benadryl (diphenhydramine) and busPIRone (buspirone) for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinue Benadryl and Consider FDA-Approved Sleep Medications

You should stop using Benadryl (diphenhydramine) for sleep immediately, as it is explicitly not recommended for insomnia treatment, and instead consider FDA-approved options like eszopiclone, zolpidem, or temazepam. 1

Why Benadryl Should Be Discontinued

  • The American Academy of Sleep Medicine explicitly recommends against diphenhydramine for treating insomnia, showing only an 8-minute reduction in sleep latency and 12-minute improvement in total sleep time compared to placebo—with no improvement in subjective sleep quality. 1
  • Diphenhydramine provides minimal clinical benefit (mean improvement of 12 minutes total sleep time with confidence intervals ranging from 13 minutes worse to 38 minutes better). 1
  • Antihistamines like Benadryl have poorly established efficacy for long-term insomnia treatment and carry risks of cognitive impairment, especially when combined with other CNS-active medications. 1

Recommended Sleep Medication Options

First-Line FDA-Approved Medications:

Eszopiclone (2-3 mg) is the strongest option, providing:

  • 28-57 minutes longer total sleep time versus placebo 1
  • 10-14 minutes reduction in wake after sleep onset 1
  • Moderate-to-large improvement in sleep quality 1
  • No short-term usage restriction 1

Zolpidem (10 mg) offers:

  • 29 minutes longer total sleep time versus placebo 1
  • 25 minutes reduction in wake after sleep onset 1
  • Moderate improvement in sleep quality 1
  • Caution: FDA requires lower doses (5 mg) due to next-morning impairment risk 1

Temazepam (15 mg) provides:

  • 99 minutes longer total sleep time versus placebo (the largest improvement among all agents) 1
  • Small improvement in sleep quality 1
  • Short-to-intermediate acting benzodiazepine 1

Alternative Options:

Suvorexant for sleep maintenance:

  • 16-28 minutes reduction in wake after sleep onset 1
  • 10 minutes longer total sleep time 1

Low-dose doxepin (3-6 mg) for sleep maintenance:

  • 14-30 minutes reduction in wake after sleep onset 1
  • Small-to-moderate improvement in sleep quality 1

Critical Safety Considerations with Buspirone

  • Buspirone does not have sedative or hypnotic effects and should not be expected to help with sleep. 2
  • Buspirone lacks the hypnotic, anticonvulsant, and muscle relaxant properties of benzodiazepines. 3
  • Combining multiple CNS-active medications (Benadryl + buspirone + new sleep medication) increases risk of additive CNS depression, cognitive impairment, and psychomotor effects. 1
  • Buspirone requires 1-2 weeks to achieve anxiolytic effects, so it should be continued for anxiety management. 3, 4

Important Drug Interaction Warnings

  • Avoid combining benzodiazepines with other CNS depressants due to additive psychomotor impairment and risk of tolerance/dependence. 1
  • All sedative-hypnotics should be taken on an empty stomach to maximize effectiveness. 1
  • Never combine sleep medications with alcohol or use multiple sedating agents simultaneously without clear medical justification. 1
  • Allow appropriate sleep time (7-8 hours) before activities requiring alertness to minimize next-day impairment. 1

Practical Implementation Algorithm

  1. Immediately discontinue diphenhydramine 1
  2. Continue buspirone for anxiety management (it will not help sleep) 3, 2
  3. Start with eszopiclone 2-3 mg at bedtime as the most effective option 1
  4. If eszopiclone is unavailable or not tolerated, use zolpidem 5-10 mg (start with 5 mg due to FDA warnings) 1
  5. For patients requiring longer-acting agents or with significant sleep maintenance issues, consider temazepam 15 mg 1
  6. Use the lowest effective dose for the shortest duration possible 1
  7. Reassess need for continued pharmacotherapy regularly 1

Common Pitfalls to Avoid

  • Do not use trazodone as first-line therapy—it is explicitly not recommended by the American Academy of Sleep Medicine for insomnia, showing no improvement in sleep quality. 1, 5
  • Do not use melatonin—it provides only 9 minutes reduction in sleep latency with small improvement in quality. 1
  • Do not continue diphenhydramine thinking "something is better than nothing"—the evidence shows it doesn't work. 1
  • Avoid benzodiazepines in elderly patients due to increased risk of cognitive impairment and falls. 1
  • Do not abruptly discontinue benzodiazepines if already taking them—taper to avoid withdrawal symptoms. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trazodone for Insomnia Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.